Alopexx, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Alopexx Enterprises, LLC
  • Alopexx Vaccine, LLC
  • Alopexx Pharmaceuticals, LLC
  • Alopexx Oncology LLC
See more in Biomedtracker

Latest on Alopexx, Inc.

Scrip

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely

Scrip

Deal Watch: Lilly, AbCellera Partner To Attempt Rapid COVID-19 Antibody Development

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . AbCellera Optimizing 500 Pot

Pink Sheet

Financings Of The Fortnight Puts On The Weight

 
• By Alex Lash and Paul Bonanos

It didn't take long for Vivus Inc. to digest the impact of acing its FDA advisory committee review on Feb. 22. One week later, it went to the public markets for a stock sale, which we describe bel

Scrip

Start-Up Quarterly Statistics, Q4 2009

 
• By Deanna Kamienski

Biopharmaceutical, medical device, and in vitro diagnostics start-up dealmaking from October through December 2009. Data from Elsevier's Strategic Transactions. Deanna F. Deinzer Financings Biopharma,